Evidence map›Paper›PMID 38018405›Full record

Observational studyTherapeutic advances in respiratory disease

Comparison of clinical outcomes in critically ill COVID-19 patients on mechanical ventilation with nosocomial pneumonia between Alpha and Omicron variants.

Chuan-Yen Sun, Jhong-Ru Huang, Hsiao-Chin Shen, Ying-Ting Liao, Hung-Jui Ko, Chih-Jung Chang, Yuh-Min Chen, Jia-Yih Feng, Wei-Chih Chen, Kuang-Yao Yang

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Chuan-Yen SunDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei.ORCID 0009-0001-7969-4679
Jhong-Ru HuangDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei.
Hsiao-Chin ShenDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei.
Ying-Ting LiaoDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei.
Hung-Jui KoDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei.
Chih-Jung ChangDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei.
Yuh-Min ChenDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei.
Jia-Yih FengDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei.
Wei-Chih ChenRoom 530, 14 floor Chung-Cheng Building, No.2o1, Sec.2, Shipai Rd., Beitou District, Taipei City, Taipei City, Taiwan.
Kuang-Yao YangDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei.ORCID 0000-0002-2803-980X
Taipei Veterans General Hospital · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a pandemic that has resulted in millions of deaths worldwide. Critically ill COVID-19 patients who require intubation and develop nosocomial pneumonia, commonly caused by gram-negative bacilli, have a higher mortality rate than those without nosocomial pneumonia.

objectivesThe aim of this study is to compare the clinical characteristics and outcomes and associated risk factors of Alpha and Omicron SARS-CoV-2 variants in critically ill patients on mechanical ventilation (MV) with nosocomial pneumonia.

designThis is a retrospective single-center cohort study.

methodsThis observational study was conducted at Taipei Veterans General Hospital, Taiwan from May 2021 to September 2022. Critically ill patients who had confirmed SARS-CoV-2 infection and intubated on a MV with bacterial pneumonia were enrolled. Demographic data, laboratory results, and treatment information were collected and analyzed. In addition, clinical outcomes among different SARS-CoV-2 variants were examined.

resultsThis study included 94 critically ill COVID-19 patients who required intubation and intensive care unit (ICU) admission. The Alpha group had a longer duration of SARS-CoV-2 viral shedding, MV days, and ICU stay, while the Omicron group had older age, more comorbidities, higher APACHE II scores, and higher in-hospital mortality (47.0%

conclusionOur study discovered a higher in-hospital mortality rate in severe COVID-19 patients with MV and secondary pneumonia infected with the Omicron variant compared to the Alpha variant; however, real independent risk factors for in-hospital mortality are malignancy, lower serum albumin level, and lack of Remdesivir treatment.

Indexed as

COVID-19Cross InfectionHealthcare-Associated PneumoniaNeoplasmsCohort StudiesCritical IllnessHumansIntensive Care UnitsRespiration, ArtificialRetrospective StudiesSARS-CoV-2Serum AlbuminSerum Albumincoronavirus disease 2019hospital-acquired pneumoniasevere acute respiratory syndrome coronavirus 2 variantsventilator-associated pneumonia

Identifiers

PMID38018405
PMCPMC10685785
OpenAlexW4389144221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.